Form 4: Corbus Pharmaceuticals Director Rachelle Jacques Acquires Restricted Stock Units
SEC Form 4 Filing
Director Rachelle Jacques received 2,783 restricted stock units (RSUs) of Corbus Pharmaceuticals Holdings, Inc. on May 30, 2024, which will vest in one year.
Summary
- Rachelle Jacques, a director of Corbus Pharmaceuticals Holdings, Inc., was granted 2,783 restricted stock units (RSUs) on May 30, 2024.
- These RSUs will vest 100% on the one-year anniversary of the grant date and will be settled in shares of common stock.
- The filing also includes a Power of Attorney, effective March 8, 2024, authorizing Yuval Cohen, Sean Moran, and Meghan Houghton to act on Jacques' behalf for SEC filings related to Corbus Pharmaceuticals.
Sentiment
Score: 7
Explanation: The document reflects a routine grant of restricted stock units, which is generally viewed neutrally to positively as it aligns director interests with shareholder value. The sentiment is slightly positive due to the incentive provided to the director.
Future Outlook
The RSUs will vest in one year, potentially increasing Jacques' holdings of Corbus Pharmaceuticals common stock.
Industry Context
Grants of restricted stock units are a common form of executive compensation in the pharmaceutical industry, aligning the interests of directors with those of shareholders.
Comparison to Industry Standards
- RSU grants are a typical component of compensation packages for directors in publicly traded companies, particularly in the biotech and pharmaceutical sectors.
- Companies like Amgen, Gilead Sciences, and Biogen often use similar equity-based compensation to incentivize their leadership.
Stakeholder Impact
- The RSU grant aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
- Employees may view the RSU grant as a positive sign of the company's commitment to its leadership.
Next Steps
- The RSUs will vest on the one-year anniversary of the grant date.
- Jacques will receive shares of common stock upon vesting of the RSUs.
Key Dates
| Date | Description |
|---|---|
| 2024-03-08 | Date of execution for Power of Attorney. |
| 2024-05-30 | Date of transaction: Grant of 2,783 restricted stock units (RSUs). |
| 2025-05-30 | RSUs will vest 100% on the one-year anniversary from the date of grant. |
| 2024-06-03 | Date of signature for the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.